Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.42%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ2.46 Billion

According to Galapagos NV's latest financial reports the company has โ‚ฌ2.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ2.89 B3.63%
2023-12-31$โ‚ฌ2.79 B10.67%
2022-12-31$โ‚ฌ2.52 B-4.44%
2021-12-31$โ‚ฌ2.64 B-1.01%
2020-12-31$โ‚ฌ2.67 B-7.14%
2019-12-31$โ‚ฌ2.87 B136.83%
2018-12-31$โ‚ฌ1.21 B19.99%
2017-12-31$โ‚ฌ1.01 B33.38%
2016-12-31$โ‚ฌ0.75 B107.86%
2015-12-31$โ‚ฌ0.36 B77.07%
2014-12-31$โ‚ฌ0.20 B23.33%
2013-12-31$โ‚ฌ0.16 B41.11%
2012-12-31$โ‚ฌ0.11 B0.06%
2011-12-31$โ‚ฌ0.11 B-20.29%
2010-12-31$โ‚ฌ0.14 B36.4%
2009-12-31$โ‚ฌ0.10 B29.12%
2008-12-31$โ‚ฌ84.32 M-14.5%
2007-12-31$โ‚ฌ98.62 M-9.97%
2006-12-31$โ‚ฌ0.10 B79.18%
2005-12-31$โ‚ฌ61.13 M489.72%
2004-12-31$โ‚ฌ10.36 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
โ‚ฌ39.48 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ68.09 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ74.12 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-โ‚ฌ2.24 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ32.1 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ44.03 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ6.23 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ18.18 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ44.58 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA